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Abstract The 70-kDa peroxisomal membrane protein
(PMP70) and the adrenoleukodystrophy protein (ALDP) are
half ATP binding cassette (ABC) transporters in the peroxisome
membrane. Mutations in the ALD gene encoding ALDP result in
the X-linked neurodegenerative disorder adrenoleukodystrophy.
Plausible models exist to show a role for ATP hydrolysis in
peroxisomal ABC transporter functions. Here, we describe the
first measurements of the rate of ATP binding and hydrolysis by
purified nucleotide binding fold (NBF) fusion proteins of PMP70
and ALDP. Both proteins act as an ATP specific binding subunit
releasing ADP after ATP hydrolysis; they did not exhibit
GTPase activity. Mutations in conserved residues of the
nucleotidases (PMP70 : G478R, S572I ; ALDP: G512S,
S606L) altered ATPase activity. Furthermore, our results
indicate that these mutations do not influence homodimerization
or heterodimerization of ALDP or PMP70. The study provides
evidence that peroxisomal ABC transporters utilize ATP to
become a functional transporter. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
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1. Introduction
The ATP binding cassette (ABC) transporter superfamily
consists of membrane proteins involved in the transport of a
variety of molecules across biological membranes [1,2]. ABC
transporters are composed of two homologous halves, each
containing a membrane-spanning region with multiple trans-
membrane segments and a nucleotide binding domain. Eu-
karyotic ABC transporters are found either as complete trans-
porters or as half transporters, which dimerize to form an
active transporter. The multiple drug resistance transporter,
MDR, and the cystic ¢brosis transmembrane regulator,
CFTR, are examples of the former while the TAP1 and
TAP2 proteins are examples of the latter [3^6]. Four half
ABC transporter proteins have been identi¢ed in the human
peroxisome membrane: the 70-kDa peroxisomal mem-
brane protein (PMP70), the adrenoleukodystrophy protein
(ALDP), the PMP70-related protein (P70R) and the ALDP-
related protein (ALDR) [7^10].
Mutations in the ALD gene encoding ALDP cause X-linked
ALD (X-ALD), the most common inherited peroxisomal dis-
order characterized by abnormal accumulation of saturated,
very long chain fatty acids predominantly in brain white mat-
ter, adrenal cortex and testis [11^14]. The biochemical defect
is localized to the level of lignoceroyl-CoA synthesis, a step in
the peroxisomal L-oxidation of very long chain fatty acids.
The exact functions of ALDP and the other peroxisomal
ABC transporters as well as their interactions are poorly
understood. Pxa1p and Pxa2p are yeast genes that encode
homologs of peroxisomal half ABC transporters. Evidence
from Pxa1 and Pxa2 mutants suggests that peroxisomal
ABC transporters are involved in the import of fatty acids
or fatty acyl-CoAs for the peroxisomal L-oxidation [15^17].
The nucleotide binding fold (NBF) motifs Walker A, Walker
B and 19-mer are conserved sequences in the carboxyl-termi-
nal half of ABC-transporters [18]. Alignment of prokaryotic
and eukaryotic NBFs reveals several highly conserved resi-
dues. The ALD gene mutations of patients with X-ALD
have a tendency to cluster in and close to the NBF [14]. To
study the role of the NBF in ABC transporters for peroxi-
some function we generated wild type and mutant constructs
of ALDP and PMP70. For the mutant constructs we selected
X-ALD patient mutations in highly conserved residues in the
Walker A and 19-mer region of the NBF of ALDP (G512S
and S606L) and the corresponding PMP70 mutations (G478R
and S572I). We overexpressed wild type and mutant proteins
in fusion with the maltose binding protein (MBP) and ana-
lyzed nucleotide binding, ATPase and GTPase activities. We
also used this expression system to assess the possible role of
the NBF in protein^protein interaction.
2. Materials and methods
2.1. Materials
We obtained reagents from the following sources: synthetic oligo-
nucleotides (MWG Biotech); pMALc2 expression vector, puri¢cation
system, T4 DNA ligase, vent DNA polymerase, restriction enzyme
XmnI, factor Xa, amylose resin (New England Biolabs); DH5K,
JM109 and TOPP I cells (Stratagene); dye terminator cycle sequenc-
ing kit (Applied Biosystems); 8-azido-[Q32P]ATP and 8-azido-
[Q32P]GTP (ICN Biochemicals); molecular size markers (Bio-Rad,
Gibco); ECL kit for Western blotting (Amersham); polyclonal rabbit
anti-rat PMP70 (W. Just, Center of Biochemistry, University of Hei-
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delberg, Heidelberg, Germany), monoclonal mouse anti-human
ALDP NBF antibody (Euromedex); pcDNA3.1 plasmid (Invitrogen);
35S-methionine (Amersham); Superdex 200 HR 10/30 column (Phar-
macia); TNT-coupled reticulocyte lysate system (Promega). All other
reagents were obtained from Boehringer or Sigma.
2.2. NBF: wild type and mutant construction
We ampli¢ed the NBF of PMP70 (amino acids (AA) 445^634) and
ALDP (AA 478^667) by using human cDNA as a template. Thirty
cycles were performed (94‡C for 1 min, 55‡C for 1 min, 72‡C for
1 min) followed by a ¢nal extension of 3 min at 72‡C. The speci¢c
primers used for PMP70 are 5P-GGAATTCCATGTTCCTTTAG-
CAACGCCA-3P (primer I with EcoRI restriction site) and 5P-
GCTCTAGACTATCACTCATGATGTTTCCAAAGAGA-3P (prim-
er II with XbaI restriction site and stop codon). The speci¢c primers
used for ALDP are 5P-AACATCCCCATCGTCACGC-3P (primer I
with blunt end) and 5P-GGAATTCAGTGGTATTTCCACAGG-
GAG-3P (primer II with EcoRI restriction site and stop codon). The
identity of all constructs was con¢rmed by sequencing.
All site-directed mutagenesis was carried out according to the mega-
primer method as described by Sarkar and Sommer [19] by using the
following oligonucleotides:
We subcloned an EcoRI^XbaI DNA fragment of the PMP70 NBF
constructs and an XmnI^EcoRI DNA fragment of the ALDP NBF
constructs into the polylinker of the pMALc2 vector. By this strategy
the NBF fragments were inserted in frame into the carboxyl-terminal
coding region of the MBP cDNA. Both strands of the inserted frag-
ments and the vector cloning sites were sequenced to con¢rm the
identity of all constructs.
2.3. Transformation in JM109 and TOPP I competent cells
Isolated plasmid DNA was transformed using competent Escheri-
chia coli JM109 cells for the PMP70 NBF constructs and E. coli
TOPP I cells for the ALDP NBF constructs according to standard
procedures.
2.4. Overexpression and puri¢cation of pMALc2 NBF fusion proteins
E. coli JM109 cells or TOPP I cells harboring the appropriate
recombinant plasmid were grown at 37‡C in LB medium with 200
Wg ampicillin/ml and 12 mM glucose. At a cell density of 0.5
(OD600) protein expression was induced with 0.3 mM isopropyl-1-
thio-L-D-galactopyranoside (IPTG) for 2 h. Cells were harvested by
centrifugation at 4000Ug at 4‡C for 20 min, resuspended and washed
once with ice cold PBS. All following puri¢cation steps were carried
out at 4‡C. Cells were resuspended in 10 ml lysis bu¡er (20 mM Tris^
HCl, pH 7.4, 200 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.25 ml
protease inhibitor) per gram wet weight and lysed by ultrasound so-
ni¢cation with short pulses in an ice bath for 2 min. The lysate was
diluted 1:4 with 1Ucolumn bu¡er (20 mM Tris^HCl, pH 7.4, 200
mM NaCl, 1 mM EDTA, 0,1% Triton X-100) and centrifuged at
10 000Ug for 20 min. The supernatant was applied to a 12-ml amy-
lose column equilibrated with column bu¡er. The column was ¢rst
washed extensively with eight column volumes of column bu¡er. The
fusion proteins were then eluted with column bu¡er containing 10
mM maltose. The eluted fractions were monitored by their absorption
at 280 nm and subsequently analyzed by SDS^PAGE as described by
Laemmli [20] and by Western blotting using a polyclonal rabbit anti-
rat PMP70 antibody, a monoclonal mouse anti-human ALDP NBF
antibody or a monoclonal mouse anti-MBP antibody. Protein concen-
trations were determined by the method of Lowry [21].
2.5. Photoa⁄nity labeling with 8-azido-[Q 32P]ATP and
8-azido-[Q 32P]GTP
2^4 Wg of fusion protein was incubated in reaction bu¡er containing
2 mM MnCl2, 10 mM MgCl2 in the presence of either 3.5 WM 8-
azido-[Q32P]ATP or 5.5 WM 8-azido-[Q32P]GTP. Some samples also
contained 50 mM ATP, AMP or GTP. All samples were incubated
at 0‡C for 20 min, exposed to UV light at 0‡C for 5 min, boiled with
SDS^PAGE loading bu¡er for 2 min and analyzed on SDS^PAGE.
The gels were dried and subjected to autoradiography. Exposure time
of autoradiography was 2 h for ATP labeling and 10 h for GTP
labeling. The identity of the labeled bands was con¢rmed by Western
blotting.
2.6. Coupled assay for ATPase or GTPase activity
A coupled ATP or GTP regenerating enzyme system was used
following the method described by Norby [22]. 2^11 WM fusion pro-
tein was incubated in a total volume of 360 Wl with 3 mM phospho-
enolpyruvate, 2.4 mM NADH, 6.5 mM magnesium acetate, 34 mM
KCl, 4.17 Wg (1.9 U) lactate dehydrogenase and 12.5 Wg (1.9 U) py-
ruvate kinase in 50 mM Tris^HCl, pH 7.5 at 25‡C. Increasing
amounts of ATP or GTP (2.8^2055 WM) were added and vA340/vt
was monitored.
2.7. In vitro translation and 35S-methionine labeling of peroxisomal
ABC transporter proteins
For in vitro translation and labeling, full length ALDP and PMP70
were cloned into pcDNA3.1 plasmid. The proteins were transcribed in
vitro from the T7-promoter of pcDNA3.1, translated and labeled with
35S-methionine using a TNT-coupled reticulocyte lysate system fol-
lowing standard protocols.
2.8. In vitro interaction assay
The puri¢ed MBP fusion proteins were bound to amylose resin in
column bu¡er (20 mM Tris^HCl, pH 7.4, 200 mM NaCl, 1 mM
EDTA, 0.1% Triton X-100) for 1 h at 4‡C and washed three times
in column bu¡er. For the in vitro interaction assay the MBP fusion
proteins (1.5^2 Wg protein bound to 5 Wl matrix suspension) were
incubated with 5 Wl of in vitro translated protein in 100 Wl binding
bu¡er (50^500 mM NaCl, 50 mM potassium phosphate pH 7.4, 1 mM
MgCl2, 1^10% glycerol, 0.1% Tween 20, 1.5% bovine serum albumin
(BSA)) for 2 h at 4‡C. Samples were pelleted and washed four times in
1 ml binding bu¡er without BSA. Pellets were resuspended in SDS
sample bu¡er and boiled for 5 min before being analyzed by SDS^
PAGE according to standard protocols. To verify stability of the
MBP fusion proteins and equal loading, gels were stained with Coo-
massie blue. The gels were dried and exposed to X-ray ¢lm for 24 h.
2.9. Gel ¢ltration chromatography of puri¢ed NBF fusion proteins
Puri¢ed wild type ALDP or PMP70 NBF fusion proteins were
centrifuged at 10 000Ug for 10 min. 100 Wl of the supernatant was
applied to a 24-ml Superdex 200 HR 10/30 column equilibrated with
column bu¡er, the column run was at a £ow rate of 0.5 ml/min. The
eluted fractions were monitored by their absorption at 280 nm and
subsequently analyzed by SDS^PAGE. The molecular weight was
determined by comparing the ratio of Velution/Vvoid for the eluted
proteins with the ratio of Velution/Vvoid for protein standards.
3. Results
3.1. Characterization of the NBF protein motif
Fig. 1 shows alignment of NBF motifs from the peroxisom-
al family of ABC transporters. These proteins exhibit the
highest similarity in the Walker A and 19-mer region. We
mutated the central glycine in the Walker A motif of
PMP70 and ALDP making the evolutionary severe substitu-
tions G478R and G512S. Additionally, we changed the con-
served serine in the 19-mer motif of PMP70 and ALDP to
isoleucine (S572I) and leucine (S606L), respectively.
3.2. Overexpression and puri¢cation of fusion proteins
The NBF of PMP70 and ALDP was expressed in fusion
with the MBP in E. coli. The K-subunit of L-galactosidase (L-
Protein Synthetic oligonucleotide Mutation
ALDP 5P-CCCCAATGGCTGCAGCAAGAGCTCCC-3P G512S
5P-GGATCCGGACAGGGAGCTCTTGCTGCAGC-3P
ALDP 5P-ACTGGAAGGACGTCCTGTTGGG-3P S606L
5P-CGCCACCCAACAGGACGTCCTTCC-3P
PMP70 5P-GGCTGCAGAAAGAGTTCACTTTTCCG-3P G478R
5P-GGCCATAATTCACCAAGAACACGGAAA
AGTGAACTCTTTCTG-3P
PMP70 5P-GACGTACTCATTGGTGGAG-3P S572I
5P-CCACCAATGAGTACGTCCATCCAATCC-3P
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gal) in fusion with the MBP was used as a control. Overex-
pression of the fusion proteins under control of the tac pro-
moter after induction with IPTG revealed highest expression
levels by using E. coli TOPPI cells for ALDP constructs and
E. coli JM109 cells for PMP70 constructs and L-gal. In con-
trast, overexpression of these fusion proteins in E. coli DH5K
cells resulted in negligible protein amounts. Fig. 2 shows that
L-gal and the NBF of PMP70 are strikingly overexpressed
upon induction and constitute a main component of the bac-
terial cell lysate. Protein expression levels for the NBF of
ALDP are signi¢cantly lower when compared with PMP70.
Nevertheless, induction with IPTG is also evident for ALDP
when the induced expression level is compared with the unin-
duced cell lysate. The expression levels of the mutant PMP70
and ALDP fusion proteins were equal to the corresponding
wild type protein levels (data not shown). Most of the over-
expressed fusion proteins are soluble and have the expected
molecular size of 64 kDa (42.7 kDa for MBP+21.4 kDa for
ALDP NBF; 42.7 kDa for MBP+21.7 kDa for PMP70 NBF).
As the MBP exhibits a high a⁄nity for amylose, the puri¢ca-
tion of the fusion proteins by amylose column a⁄nity chro-
matography was very e¡ective. A yield of 5^10 mg or 10^20
mg of puri¢ed protein per liter of cell culture was achieved for
ALDP and PMP70 constructs, respectively. A variety of
prominent protein bands smaller than 64 kDa were present
in the puri¢ed ALDP NBF fusion proteins. These bands were
shown to be truncated fusion proteins by immunoblotting
and amino-terminal sequence analyses. The purity of the
NBF fusion proteins was estimated from SDS^PAGE to
be s 95% pure (Fig. 3).
We further characterized all fusion proteins by immuno-
blotting using antiserum to MBP, PMP70 and the NBF of
ALDP. The pattern of the MBP immunoblot (Fig. 4A) was
identical to the one of the Coomassie-blue-stained SDS^
PAGE gel (Fig. 3). All bands smaller than 64 kDa corre-
sponded to truncated fusion proteins. The ALDP immunoblot
(Fig. 4B) as well as the PMP70 immunoblot (Fig. 4C) revealed
bands of the expected molecular size of 64 kDa indicating that
the NBFs of ALDP and PMP70 are inserted in frame and
that the integrity of the NBF was maintained during puri¢ca-
tion. The antiserum to the ALDP NBF did not show any
cross reactivity to the PMP70 NBF.
3.3. Nucleotide binding function of ALDP and PMP70
The puri¢ed NBF fusion proteins were photoa⁄nity-labeled
with 8-azido-[Q32P]ATP or 8-azido-[Q32P]GTP. BSA, an ATP
and GTP binding protein, was used as a control [23,24]. The
corresponding 64-kDa protein band of the photolabeled
ALDP or PMP70 NBF domain was identi¢ed by immuno-
blotting with speci¢c antibodies. Fig. 5 shows that the puri¢ed
NBF fusion proteins are labeled by 8-azido-[Q32P]ATP. There
was no major di¡erence in the level of ATP binding between
the ALDP and PMP70 NBF domains. In contrast to the
striking ATP binding, there was only a weak 8-azido-
[Q32P]GTP band for ALDP and PMP70 NBF (data not
shown). The exposure time for getting ATP- and GTP-labeled
bands of the same intensity is ¢ve times longer for GTP than
for ATP indicating that ATP is the predominant substrate for
Fig. 1. Alignment of NBF motifs and position of mutations. Listed human peroxisomal ABC transporters from top to bottom are HsPMP70,
HsP70R, HsALDP and HsALDR. AA present in a plurality of these sequences are boxed in black. Missense mutations produced are indicated
above. G512S and S606L cause X-ALD.
Fig. 2. Overexpressed NBF fusion proteins. 75 Wl of bacterial cell
lysate of E. coli JM109 cells containing recombinant plasmid of L-
gal or PMP70 wild type (wt) and E. coli TOPP I cells containing
the recombinant plasmid of ALDP wild type (wt) were solubilized
in SDS sample bu¡er and separated by SDS^PAGE. The lanes des-
ignated as T0 correspond to uninduced cells, the lanes marked as
T1, T2 and T3 to cell lysate 1, 2 and 3 h after IPTG induction, re-
spectively. Both NBF proteins exhibit an approximate molecular
mass of 64 kDa.
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ALDP and PMP70. BSA was labeled by 8-azido-[Q32P]ATP
and also by 8-azido-[Q32P]GTP. In contrast to previous studies
[25], we found a very weak ATP and GTP binding of L-gal in
fusion with MBP. Labeling of all fusion proteins could be
inhibited if the sample was preincubated with non-radioactive
nucleotides prior to photoa⁄nity labeling.
3.4. ATPase and GTPase activity of ALDP and PMP70
For investigating the intrinsic ATPase and GTPase activity
of the puri¢ed ALDP and PMP70 fusion proteins a coupled
ATP or GTP regenerating enzyme system was used. The assay
monitors the formation of ADP coupled to the pyruvate ki-
nase and lactic dehydrogenase reactions by photometric anal-
ysis. We did not detect any ATPase activity neither for the L-
gal fusion protein nor for MBP. Since the MBP is not a nu-
cleotide binding protein, we measured ATPase and GTPase
activities of PMP70 and ALDP in fusion with the MBP and
did not cleave the NBF protein motif before analysis. The
wild type and mutant ALDP and PMP70 NBF fusion pro-
teins were able to hydrolyze ATP (Fig. 6). The hydrolysis rate
of the fusion proteins was found to be linear to the di¡erent
protein concentrations examined. We obtained a typical Mi-
chaelis^Menten curve by plotting ATPase activity versus ATP
concentration. Results from di¡erent assay procedures are
summarized in Table 1. The S606L and G478R mutants
have a decreased ATP binding a⁄nity while the G512S and
S572I mutants decrease the maximum velocity of ATPase ac-
tivity. Using an analogous assay for GTPase activity measure-
ment we could not detect any GTPase activity for ALDP and
PMP70 NBF fusion proteins.
3.5. NBF domain interactions of ALDP and PMP70
To determine if the NBF is involved in dimerization, we
incubated the puri¢ed NBF fusion proteins with the corre-
sponding in vitro translated and labeled full length ABC
transporter protein. We analyzed these samples on SDS^
PAGE. When testing the NBF of wild type ALDP and wild
type PMP70 as well as the NBF of the mutant ALDP (G512S)
against full length ALDP or full length PMP70, only back-
ground levels were detected (data not shown). These results
indicate that the NBF domain is not necessary and su⁄cient
for homodimerization or heterodimerization of ALDP and
PMP70.
We also analyzed the dimerization capability of wild type
NBF fusion proteins by gel ¢ltration chromatography. The
elution pro¢les of both NBF fusion proteins were comparable
and showed a single peak at 64 kDa. We did not detect a peak
in the molecular weight region of approximately 130 kDa, the
region for heterodimerized or homodimerized NBF fusion
proteins. These results con¢rmed our previous results that
there is no evidence for protein^protein interaction in the
NBF of PMP70 and ALDP.
4. Discussion
ABC transporters are present in all cellular living organisms
and are involved in the transport of a variety of substrates
across membranes [1,2]. Mutations in genes encoding ABC
transporters are responsible for genetic diseases including
the CFTR gene for cystic ¢brosis and the ALD gene for X-
ALD [8,26,27]. Several recent studies suggest that the carbox-
yl-terminal halves of these proteins including the NBF play an
important role in protein function. Missense mutations in the
NBF conserved sequences Walker A, Walker B and 19-mer
in£uence substrate speci¢city and nucleotide binding [26,27].
Fig. 4. Immunoblot of NBF fusion proteins. 1 Wg of lysate or puri¢ed fusion proteins were analyzed including L-gal, wild type PMP70 and
ALDP, BSA, PMP70 and ALDP mutants. Rabbit antiserum to either MBP (A) or PMP70 (C) and mouse antiserum to the NBF of ALDP (B)
were used. The wild type and mutant NBF fusion proteins have an approximate molecular mass of 64 kDa. Lys, lysate; Pfp, puri¢ed fusion
protein.
Fig. 3. Overexpressed and puri¢ed wild type and mutant NBF fu-
sion proteins. 3 Wg of each fusion protein puri¢ed by amylose a⁄n-
ity chromatography were subjected to SDS^PAGE. The fusion pro-
teins used are L-gal, wild type PMP70 and ALDP, PMP70 and
ALDP mutants; BSA was used as a control. The wild type and mu-
tant NBF fusion proteins have an approximate molecular mass of
64 kDa.
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Liu and co-workers have shown that homo- as well as hetero-
dimerization occurs between the carboxyl-terminal halves of
ALDP, ALDRP and PMP70 [28]. We utilized recombinant
polypeptide models to analyze di¡erent possible functions of
the NBF in peroxisomal ABC transporters, namely ATP
binding, ATPase activity and protein^protein interactions.
Contreras and co-workers [29] revealed that the NBF of
ALDP is on the cytoplasmic surface of peroxisomal mem-
branes and able to bind ATP. Moreover, we found that the
NBF of ALDP and PMP70 can bind ATP and function as an
ATPase. Our studies also provide evidence that ALDP and
PMP70 are also GTP binding proteins. To further character-
ize the NBF, we applied site-directed mutagenesis in the genes
encoding ALDP and PMP70. We found that mutations in
conserved residues in the Walker A and 19-mer region alter
ATPase activity. The missense mutation G512S in the ALD
gene causes X-ALD and reduces considerable ATPase activity
in our recombinant polypeptide models. This observation sug-
gests that the peroxisomal L-oxidation process is tightly
coupled to ATPase activity and that ATPase dysfunction
leads to the accumulation of VLCFA in X-ALD patients. In
contrast, the X-ALD patient mutation S606L alters ATP
binding a⁄nity but has no e¡ect on the overall ATPase ac-
tivity. Because the carboxyl-terminal halves of ALDP, PMP70
and ALDR are involved in protein dimerization and interac-
tions with other protein motifs like the transmembrane do-
main [28], it is possible that the S606L missense mutation in
ALDP exerts its disease causing e¡ect in this manner. How-
ever, our results indicate that the NBF domain is not neces-
sary and su⁄cient for homodimerization or heterodimeriza-
tion of ALDP and PMP70. Our results are in accordance with
the one by Liu and co-workers who by using deletion con-
structs of the carboxyl-terminal part of ALDP showed that
the critical domain for dimerization is most likely carboxyl-
terminal of the NBF [28].
Applying the pMALc2 expression system, we obtained pu-
ri¢ed soluble preparations of wild type and mutant NBFs of
peroxisomal ABC transporters. The ¢nding that the resultant
fusion proteins bind amylose, ATP and GTP and that ATPase
activity is preserved demonstrates that within the fusion com-
plex both the NBF and MBP have folded correctly to allow
formation of their respective substrate binding sites. The wild
type and mutant NBF fusion proteins were shown to be vir-
tually indistinguishable in their properties to bind ATP and
GTP. Overexpression of these fusion proteins in large
amounts and rapid puri¢cation in a single step provides an
excellent basis for future attempts to form crystals for X-ray
di¡raction structural analyses of peroxisomal ABC transport-
ers.
The speci¢c ATPase activity of the isolated NBF of human
peroxisomal ABC transporters is in the same order of magni-
tude than those of other ABC transporters including human
CFTR [30,31] and MDR [32]. ATP a⁄nity is 10^200 times
higher when compared to CFTR and MDR, respectively.
Nevertheless, the kinetic data obtained for isolated NBF do-
mains do not represent the nucleotide binding and hydrolysis
rate of complete native transporters. Previous studies on
MDR suggest that the ATPase activity of the native protein
Table 1
Kinetic parameters of ATPase activity in wild type and mutant ALDP and PMP70 NBF fusion proteins
Fusion protein KM (WM) Vmax (nmol/Wmol NBF/min) Speci¢c activity (1033 U/mg)
ALDP (wild type) 11.5 þ 0.97 641.9 þ 10.7 10.0 þ 0.17
ALDP (G512S) 17.9 þ 1.23 279.3 þ 4.2 4.4 þ 0.06
ALDP (S606L) 45.6 þ 2.40 666.0 þ 8.7 10.4 þ 0.14
PMP70 (wild type) 8.2 þ 0.52 580.8 þ 6.7 9.0 þ 0.10
PMP70 (G478R) 161.8 þ 34.40 641.2 þ 28.2 10.0 þ 0.44
PMP70 (S572I) 9.9 þ 0.82 298.1 þ 4.7 4.6 þ 0.07
The kinetic data of all fusion proteins are mean values and standard deviations of 15^20 measurements at various protein concentrations using
at least two distinct protein preparations.
Fig. 5. Photolabeling of NBF fusion proteins. Puri¢ed fusion proteins were photolabeled with 8-azido-[Q32P]ATP in the presence (+) or absence
(3) of ATP. 3 Wg of protein were analyzed including BSA, L-gal, wild type PMP70 and ALDP, PMP70 and ALDP mutants.
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is two orders of magnitude higher when compared with iso-
lated NBF. The activity is also substrate speci¢c and increased
by protein phosphorylation [32^36]. Regarding X-ALD pa-
tient mutations in the NBF, the e¡ect of these disease causing
mutations on ATPase activity or ATP binding a⁄nity is most
likely several orders of magnitude higher in the native protein
when compared to our measurements in NBF fusion proteins.
To further characterize the molecular functions and interac-
tions of human peroxisomal ABC transporters it will be nec-
essary to establish in vitro models of puri¢ed full length re-
combinant proteins with retention of the biochemical and
physiological characteristics of an ABC transporter associated
in its native peroxisomal membrane form.
In summary, our ¢ndings give the ¢rst experimental evi-
dence that the NBF of two peroxisomal ABC transporters,
ALDP and PMP70, can act as an ATP binding subunit that
releases ADP after ATP hydrolysis. Missense mutations in the
NBF cause ATPase dysfunction, and mutations in corre-
sponding residues of ALDP cause the human peroxisomal
disorder X-ALD. The NBF seems not to be directly involved
in homodimerization and heterodimerization of these ABC
transporters. Our studies indicate that recombinant polypep-
tide models are a useful system for elucidating the pathogen-
esis of ALD.
Acknowledgements: We thank Christoph Randak for his help with
ATPase activity measurements and Ralf Ho¡mann for protein se-
quencing. We are grateful for critical discussions with Adelbert
Roscher. J.G. was supported by Grants from the Deutsche For-
schungsgemeinschaft (Ga354/3-2 and 3-3).
References
[1] Higgins, C.F. (1992) Annu. Rev. Cell Biol. 8, 945^951.
[2] Higgins, C.F. (1995) Cell 82, 693^696.
[3] Germann, U.A., Pastan, I. and Gottesman, M.M. (1993) Semin.
Cell Biol. 4, 63^76.
[4] Riordan, J.R., Rommens, J.M., Kerem, B., Alon, N., Rozmahel,
R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.L.,
Drumm, M.L., Tannuzi, M.C., Collins, F.S. and Tsui, L.C.
(1998) Science 245, 1066^1073.
[5] Kelly, A., Powis, S.H., Kerr, L.A., Mockridge, I., Elliott, T.,
Bastin, J., Uchanska-Ziegler, B., Ziegler, A., Trowsdale, J. and
Townsend, A. (1992) Nature 355, 641^644.
[6] Spies, T., Cerundolo, V., Colonna, M., Cresswell, P., Townsend,
A. and DeMars, R. (1992) Nature 355, 640^646.
[7] Ga«rtner, J., Moser, H. and Valle, D. (1992) Nat. Genet. 1, 16^23.
[8] Mosser, J., Douar, A.M., Sarde, C.O., Kioschis, P., Feil, R.,
Moser, H., Poustka, A.M., Mandel, J.L. and Aubourg, P.
(1993) Nature 361, 726^730.
[9] Lombard-Platet, B., Savary, S., Sarde, C.O., Mandel, J.L. and
Chimini, G. (1996) Proc. Natl. Acad. Sci. USA 93, 1265^1269.
[10] Holzinger, A., Kammerer, S. and Roscher, A.A. (1997) Biochem.
Biophys. Res. Commun. 237, 152^157.
[11] Geel van, B.M., Assies, J., Weverling, G.J. and Barth, P.G.
(1994) Neurology 44, 2343^2346.
[12] Moser, H., Smith, K., and Moser, A. (1995) in: The Metabolic
and Molecular Bases of Inherited Disease (Scriver, C., Beaudet,
A., Sly, W., and Valle, D., Eds.), 7th edn., pp. 2325^2349,
McGraw-Hill, New York.
[13] Moser, H.W. (1997) Brain 1207, 1485^1508.
[14] Ga«rtner, J., Braun, A., Holzinger, A., Roerig, P., Lenard, H.G.
and Roscher, A.A. (1998) Neuropediatrics 29, 3^13.
[15] Shani, N., Watkins, P.A. and Valle, D. (1995) Proc. Natl. Acad.
Sci. USA 92, 6012^6016.
[16] Hettema, E.H., van Roermund, C.W.T., Distel, B., van den Berg,
M., Vilela, C., Rodrigues-Pousada, C., Wanders, R.J.A. and Ta-
bak, H.F. (1996) EMBO J. 15, 3821^3822.
[17] Shani, N., Sapag, A. and Valle, D. (1996) J. Biol. Chem. 271,
8725^8730.
[18] Walker, J., Saraste, M., Runswick, M. and Gay, N. (1982)
EMBO J. 8, 945^951.
[19] Sarkar, G. and Sommer, S.S. (1990) BioTechniques 8, 404^406.
[20] Laemmli, T.K. (1997) Nature 227, 680^685.
[21] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J.
(1951) J. Biol. Chem. 193, 265^275.
[22] Norby, J.G. (1988) Methods Enzymol. 156, 116^119.
[23] Bauer, M., Baumann, J. and Trommer, W.E. (1992) FEBS Lett.
313, 288^290.
[24] Takeda, S., Miyauchi, S., Nakayama, H. and Kamo, N. (1997)
Biophys. Chem. 69, 175^183.
[25] Ko, Y.H., Thomas, P.J., Delannoy, M.R. and Pedersen, P.L.
(1993) J. Biol. Chem. 268, 24330^24338.
[26] Cutting, G.R., Kasch, L.M., Rosenstein, B.J., Zielenski, J., Tsui,
L.C., Antonarakis, S.E. and Kazazian, H.H. (1990) Nature 346,
366^369.
[27] Sheps, J.A., Cheung, I. and Ling, V. (1995) J. Biol. Chem. 270,
14829^14834.
[28] Liu, L.X., Janvier, K., Berteaux-Lecellier, V., Cartier, N., Benar-
ous, R. and Aubourg, P. (1999) J. Biol. Chem. 274, 32738^32743.
[29] Contreras, M., Sengupta, T.K., Sheikh, F., Aubourg, P. and
Singh, I. (1996) Arch. Biochem. Biophys. 334, 369^379.
[30] Ko, Y.H. and Pedersen, P.L. (1995) J. Biol. Chem. 270, 22093^
22096.
Fig. 6. Speci¢c ATPase activity in NBF fusion proteins. Enzymatic activity of wild type and mutant ALDP (A) and PMP70 (B) was monitored
by following the formation of ADP in a coupled spectrophotometric assay. The data points are the mean values of 15^20 measurements using
at least two di¡erent protein preparations. Michaelis^Menten plots were calculated by hyperbolic curve ¢tting of mean values.
FEBS 24674 5-3-01
P. Roerig et al./FEBS Letters 492 (2001) 66^72 71
[31] Randak, C., Neth, P., Auerswald, E.A., Eckerskorn, C., Assfalg-
Machleidt, I. and Machleidt, W. (1997) FEBS Lett. 410, 180^186.
[32] Dayan, G., Baubichon-Cortay, H., Jault, J.M., Cortay, J.C.,
Deleage, G. and Di Pietro, A. (1996) J. Biol. Chem. 271,
11652^11658.
[33] Urbatsch, I.L., Al-Shawi, M.K. and Senior, A.E. (1994) Bio-
chemistry 33, 7069^7076.
[34] Loo, T.W. and Clarke, D.M. (1995) J. Biol. Chem. 270, 21449^
21452.
[35] Mu«ller, M., Bakos, E., Welker, E., Varadi, A., Germann, U.A.,
Gottesmann, M.M., Morse, B.S., Roninson, I.B. and Sarkadi, B.
(1996) J. Biol. Chem. 271, 1877^1883.
[36] Mao, Q., Leslie, E.M., Deeley, R.G. and Cole, S.P.C. (1999)
Biochim. Biophys. Acta 1461, 69^82.
FEBS 24674 5-3-01
P. Roerig et al./FEBS Letters 492 (2001) 66^7272
